Hennessy BT - Search Results

1

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.

Wiegand KC, Hennessy BT, Leung S, Wang Y, Ju Z, McGahren M, Kalloger SE, Finlayson S, Stemke-Hale K, Lu Y, Zhang F, Anglesio MS, Gilks B, Mills GB, Huntsman DG, Carey MS. Wiegand KC, et al. Among authors: hennessy bt. BMC Cancer. 2014 Feb 22;14:120. doi: 10.1186/1471-2407-14-120. BMC Cancer. 2014. PMID: 24559118 Free PMC article.

2

Exploiting the PI3K/AKT pathway for cancer drug discovery.

Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Hennessy BT, et al. Nat Rev Drug Discov. 2005 Dec;4(12):988-1004. doi: 10.1038/nrd1902. Nat Rev Drug Discov. 2005. PMID: 16341064 Review.

3

Identification of remodeling and spacing factor 1 (rsf-1, HBXAP) at chromosome 11q13 as a putative oncogene in ovarian cancer.

Hennessy BT, Nanjundan M, Cheng KW, Nolden L, Mills GB. Hennessy BT, et al. Eur J Hum Genet. 2006 Apr;14(4):381-3. doi: 10.1038/sj.ejhg.5201570. Eur J Hum Genet. 2006. PMID: 16418735 No abstract available.

4

Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling.

Hennessy BT, Mills GB. Hennessy BT, et al. Int J Biochem Cell Biol. 2006;38(9):1450-6. doi: 10.1016/j.biocel.2006.01.009. Epub 2006 Feb 21. Int J Biochem Cell Biol. 2006. PMID: 16682246 Review.

5

Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

Stemke-Hale K, Hennessy B, Mills GB, Mitra R. Stemke-Hale K, et al. Curr Oncol Rep. 2006 Nov;8(6):484-91. doi: 10.1007/s11912-006-0078-5. Curr Oncol Rep. 2006. PMID: 17040626 Review.

6

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills GB, Kornblau SM. Tibes R, et al. Mol Cancer Ther. 2006 Oct;5(10):2512-21. doi: 10.1158/1535-7163.MCT-06-0334. Mol Cancer Ther. 2006. PMID: 17041095

7

Point mutations of protein kinases and individualised cancer therapy.

Davies M, Hennessy B, Mills GB. Davies M, et al. Expert Opin Pharmacother. 2006 Nov;7(16):2243-61. doi: 10.1517/14656566.7.16.2243. Expert Opin Pharmacother. 2006. PMID: 17059381 Review.

8

Non-parametric quantification of protein lysate arrays.

Hu J, He X, Baggerly KA, Coombes KR, Hennessy BT, Mills GB. Hu J, et al. Among authors: hennessy bt. Bioinformatics. 2007 Aug 1;23(15):1986-94. doi: 10.1093/bioinformatics/btm283. Epub 2007 Jun 28. Bioinformatics. 2007. PMID: 17599930

9

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, Linn SC, Gonzalez-Angulo AM, Stemke-Hale K, Hauptmann M, Beijersbergen RL, Mills GB, van de Vijver MJ, Bernards R. Berns K, et al. Among authors: hennessy bt. Cancer Cell. 2007 Oct;12(4):395-402. doi: 10.1016/j.ccr.2007.08.030. Cancer Cell. 2007. PMID: 17936563 Free article. Clinical Trial.

10

Pharmacodynamic markers of perifosine efficacy.

Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Carey MS, Ravoori M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB. Hennessy BT, et al. Clin Cancer Res. 2007 Dec 15;13(24):7421-31. doi: 10.1158/1078-0432.CCR-07-0760. Clin Cancer Res. 2007. PMID: 18094426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page